Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Adolescent and young adult leukemia survivors have reduced long-term survival compared to peers without cancer

Adolescent and young adult leukemia survivors have reduced long-term survival compared to peers without cancer

Unique binding property may explain the ability of delta variant to spread more rapidly

Unique binding property may explain the ability of delta variant to spread more rapidly

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

Targeting the mitochondrial pathway may be a potential strategy to halt prostate cancer growth

Targeting the mitochondrial pathway may be a potential strategy to halt prostate cancer growth

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

The Josep Carreras Leukaemia Research Institute joins Cancer Proteome Project

The Josep Carreras Leukaemia Research Institute joins Cancer Proteome Project

Novel method could bring life-saving benefits of CAR T-cell therapy to patients with acute myeloid leukemia

Novel method could bring life-saving benefits of CAR T-cell therapy to patients with acute myeloid leukemia

Novel plug-and-play multi-organ chip can be customized to the patient

Novel plug-and-play multi-organ chip can be customized to the patient

CRISPR/Cas9 deletions induce adverse on-target genomic effects

CRISPR/Cas9 deletions induce adverse on-target genomic effects

Study determines how much U.S. hospitals mark up the price of cancer therapies

Study determines how much U.S. hospitals mark up the price of cancer therapies

Scientists identify innovative treatment approach for arterial thromboses

Scientists identify innovative treatment approach for arterial thromboses

CAR TCell Therapy: The Future of Cancer and HIV Treatment?

CAR TCell Therapy: The Future of Cancer and HIV Treatment?

Researchers discover a novel signaling pathway that defines interferon responses in blood cancers

Researchers discover a novel signaling pathway that defines interferon responses in blood cancers

New chemical reaction creates a faster, simpler way of making tertiary amines for medicines

New chemical reaction creates a faster, simpler way of making tertiary amines for medicines

A comprehensive rule book for the design of safe and efficient therapeutic cells

A comprehensive rule book for the design of safe and efficient therapeutic cells

Researchers identify certain gene regulation signatures in CAR T-resistant leukemia patients

Researchers identify certain gene regulation signatures in CAR T-resistant leukemia patients

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Unique heightened aggregation of SARS-CoV-2 Delta variant spike pseudotyped particles

Unique heightened aggregation of SARS-CoV-2 Delta variant spike pseudotyped particles

Therapies for LGL leukemia should target the immune system, not only cancer cells

Therapies for LGL leukemia should target the immune system, not only cancer cells